Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Rheumatoid Arthritis

Free Subscription Articles published in Curr Opin Rheumatol Retrieve available abstracts of 15 articles: HTML format

Single Articles

March 2026
1. PENG Y, Belcher DJ, Kobryn A, Cole CL, et al
   Synovial lymphatic system structure and function in rheumatoid arthritis: lymphatic phases, telocytes, and therapeutic modulation through Eexercise.
   Curr Opin Rheumatol. 2026 Mar 4. doi: 10.1097/BOR.0000000000001151.
   PubMed     Abstract available
   
   
   
2. MASSAY R, Malani A, Stubbs A
   Glucagon-like peptide-1 receptor agonists in rheumatoid arthritis.
   Curr Opin Rheumatol. 2026 Mar 4. doi: 10.1097/BOR.0000000000001153.
   PubMed     Abstract available
   
   
   
3. KLINGEMANN LE, Mikuls TR, England BR
   Epidemiology and outcomes of rheumatoid arthritis.
   Curr Opin Rheumatol. 2026;38:69-75.
   PubMed     Abstract available
   
   
   February 2026
4. TIONG BK, Dahhan T
   Selective immunoglobulin E deficiency: an overlooked hypogammaglobulinemia and its association with rheumatoid arthritis.
   Curr Opin Rheumatol. 2026 Feb 26. doi: 10.1097/BOR.0000000000001150.
   PubMed     Abstract available
   
   
   January 2026
5. TSIRONIS C, Karampela AI, Mavragani CP
   Advances in the diagnosis and treatment of Sjogren disease.
   Curr Opin Rheumatol. 2026;38:38-44.
   PubMed     Abstract available
   
   
   May 2024
6. FOX DA
   Rheumatoid arthritis - the challenge of heterogeneity.
   Curr Opin Rheumatol. 2024;36:201-202.
   PubMed    
   
   
   
7. JOHNSON NM, Koumpouras F
   Chimeric antigen receptors: "CARs" in the fast lane for rheumatology.
   Curr Opin Rheumatol. 2024;36:176-183.
   PubMed     Abstract available
   
   
   March 2024
8. DEANE KD
   Rheumatoid arthritis: prediction of future clinically-apparent disease, and prevention.
   Curr Opin Rheumatol. 2024 Mar 6. doi: 10.1097/BOR.0000000000001013.
   PubMed     Abstract available
   
   
   
9. BARTH K, Gill H, Singh N
   Long-term safety of biologic and targeted synthetic disease modifying drugs in rheumatology.
   Curr Opin Rheumatol. 2024;36:113-119.
   PubMed     Abstract available
   
   
   February 2024
10. STEINER G, Toes REM
    Autoantibodies in rheumatoid arthritis - rheumatoid factor, anticitrullinated protein antibodies and beyond.
    Curr Opin Rheumatol. 2024 Feb 27. doi: 10.1097/BOR.0000000000001006.
    PubMed     Abstract available
    
    
    
11. MYASOEDOVA E, Matteson EL
    Updates on interstitial lung disease and other selected extra-articular manifestations of rheumatoid arthritis.
    Curr Opin Rheumatol. 2024 Feb 26. doi: 10.1097/BOR.0000000000001007.
    PubMed     Abstract available
    
    
    
12. PARK E, Bathon J
    Cardiovascular complications of rheumatoid arthritis.
    Curr Opin Rheumatol. 2024 Feb 12. doi: 10.1097/BOR.0000000000001004.
    PubMed     Abstract available
    
    
    January 2024
13. WALLACE BI, Cooney L, Fox DA
    New molecular targets in the treatment of rheumatoid arthritis.
    Curr Opin Rheumatol. 2024 Jan 3. doi: 10.1097/BOR.0000000000001000.
    PubMed     Abstract available
    
    
    November 2023
14. COHEN S, Reddy V
    Janus kinase inhibitors: efficacy and safety.
    Curr Opin Rheumatol. 2023;35:429-434.
    PubMed     Abstract available
    
    
    September 2023
15. NEUMANN E, Heck C, Muller-Ladner U
    Recent developments in the synovial fibroblast pathobiology field in rheumatoid arthritis.
    Curr Opin Rheumatol. 2023 Sep 13. doi: 10.1097/BOR.0000000000000978.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum